AI Summary & Key Takeaways
AI InsightSurgery option keeps it validity as the most important weapon against all stages and cell types in lung cancer.
📌 3 Key Takeaways
Abstract
Lung cancers are the most common solid organ cancers and are responsible for a major part of cancer deaths. They account for1/3 or 1/4 of all deaths from cancer. Small cell lung cancers (SCLC) are known for having very poor outcomes in survival analyses,despite multiple treatment applications. Even though the traditional literature claims that treatment of this disease is essentiallymedical, surgical experiences do not confirm such claim. In this study, we examined whether small cell lung cancer is a non-surgicaldisease as it is believed to be. The medical literature in the thoracic and cardiovascular surgery and oncology network wasreviewed, and studies, cases, and meta-analysis articles that provided small cell lung cancer treatment outcomes were examined.A discussion was made by also analyzing the survival data in the light of the available guidelines. It is seen that treatment of smallcell lung cancer is not mainly medical and that the surgical option can be administered similarly to non-small cell lung cancer(NSCLC). Unfortunately, even the targeted treatment options do not provide recovery at a satisfactory level in the current state ofcancer treatment. Surgery option keeps it validity as the most important weapon against all stages and cell types in lung cancer.